Collegium Pharmaceutical (COLL) Insider Trading & Ownership → I spent 44 years on Wall Street. If you knew what I know, you’d be terrified too. (From InvestorPlace) (Ad) Free COLL Stock Alerts $32.20 -0.24 (-0.74%) (As of 06/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Collegium Pharmaceutical (NASDAQ:COLL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.98%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$5.53 M Get COLL Insider Trade Alerts Want to know when executives and insiders are buying or selling Collegium Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COLL Insider Buying and Selling by Quarter Ad Weiss RatingsYour bank account could be compromisedLegendary financial forecaster, Dr. Martin Weiss has recently uncovered the government's chilling new program that could radically change America forever. If you have any kind of money in an American bank, your financial future could be compromised.Click here and follow the three simple steps Martin shares to protect your savings Collegium Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/28/2024Colleen TupperCFOSell19,710$34.21$674,279.10 5/24/2024Scott DreyerEVPSell56,807$33.98$1,930,301.86 5/14/2024Garen G BohlinDirectorSell28,985$32.30$936,215.50 1/16/2024Scott DreyerEVPSell23,560$32.28$760,516.80 12/21/2023Joseph CiaffoniCEOSell4,357$30.38$132,365.66 12/19/2023Joseph CiaffoniCEOSell14,516$30.03$435,915.48 11/27/2023Shirley R KuhlmannEVPSell25,600$25.78$659,968.00 (Data available from 1/1/2013 forward) COLL Insider Trading Activity - Frequently Asked Questions Who is on Collegium Pharmaceutical's Insider Roster? The list of insiders at Collegium Pharmaceutical includes Colleen Tupper, Garen G Bohlin, Joseph Ciaffoni, Michael Thomas Heffernan, Scott Dreyer, and Shirley R Kuhlmann. Learn more on insiders at COLL. What percentage of Collegium Pharmaceutical stock is owned by insiders? 3.98% of Collegium Pharmaceutical stock is owned by insiders. Learn more on COLL's insider holdings. Which Collegium Pharmaceutical insiders have been selling company stock? The following insiders have sold COLL shares in the last 24 months: Colleen Tupper ($1,501,834.40), Garen G Bohlin ($936,215.50), Joseph Ciaffoni ($4,266,166.18), Michael Thomas Heffernan ($1,869,314.79), Scott Dreyer ($3,535,042.72), and Shirley R Kuhlmann ($2,340,166.39). How much insider selling is happening at Collegium Pharmaceutical? Insiders have sold a total of 564,458 Collegium Pharmaceutical shares in the last 24 months for a total of $14,448,739.98 sold. More Insider Trading Tools from MarketBeat Related Companies: INZY Insider Buying NKTR Insider Buying EGRX Insider Buying ALKS Insider Buying RNA Insider Buying AXSM Insider Buying CRNX Insider Buying PRGO Insider Buying PBH Insider Buying MRUS Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Is CAVA Overextended? A Closer Look at This High-Flying StockOccidental Petroleum: Buffett Causes OXY Stock Rebound3 Tech Stocks Insiders, Major Shareholders, and Institutions BuyThe Top 3 Stocks Sold by Insiders This QuarterTop 4 Stocks With Notable Insider Buying This page (NASDAQ:COLL) was last updated on 6/30/2024 by MarketBeat.com Staff From Our PartnersElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | SponsoredHistoric NVIDIA partnership could send this tiny AI stock soaring...After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's...Behind the Markets | SponsoredYour bank account could be compromisedLegendary financial forecaster, Dr. Martin Weiss has recently uncovered the government's chilling new program ...Weiss Ratings | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredA new pathway to wealth was born inside my wine-cellarThese days, the “right” to receive a welfare check enjoys greater popularity than the right to make a living. ...Porter & Company | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Collegium Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.